Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

As the world experiences accelerated change in technology and consumer preferences, the South African automotive industry has to embrace profound transformation to maintain its heritage of ...

(9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 ...

Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge ...

Wuthering Waves has released the second phase of its version 2.4 update featuring the Flames of Heart quest alongside a new 5 ...

Progress is being made on the new Hinds County jail. Nearly three years after breaking ground on the Hinds County Criminal ...

Star. The Mariners’ catcher won Phase 2 of the PRO SPIRIT MLB All-Star Ballot that closed on Wednesday morning over Toronto’s ...

Council members spent most of the day behind closed doors in executive session, but spent the final hour questioning officials about the potential impact of the legislation.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.

Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for ...

Between Casgevy's long-term potential and the company's innovative pipeline, CRISPR Therapeutics could eventually recover and ...